Follow the 팜젠사이언스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 팜젠사이언스 has logged 91 insider filings. Market capitalisation: €67.8bn. The latest transaction was reported on 12 May 2026 (Purchase). Among the most active insiders: 한의상. The full history is openly available.
91
Insider Decl.
0
Thresholds
€2m
65 ops.
Buy Volume
·
1 ops.
Sell Volume
22Σ signal
Buys €2m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,818 of 26,220 companies
34.1
score / 100
Value
31
Quality
37
FCF yld4.0%
Earn yld-175%
EV/EBITDA·
ROE0.1%
Gross mgn65%
Net mgn-67%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
